Healthcare
Live Price
Offline$10.09
+1.51% today
1Y Change
-44.37%
Window
Jun 20, 2025 → Jun 15, 2026
Coverage: 247 bars · Jun 20, 2025 → Jun 15, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Telix Pharmaceuticals Limited (TLX) is a Healthcare stock with a market cap of $5.28B and listed on NASDAQ. The stock last traded around $10.09 and down 44.4% across the available one-year price window (Jun 20, 2025 → Jun 15, 2026). Baseline metrics include revenue growth of +53.9%, EPS growth of -121.1%, a dividend yield of 0.0%. What stands out right now is revenue +53.9%, EPS -121.1%, free cash flow -388.4% with operating margin 2.1% and ROIC 1.8%. Valuation sits in the middle of the pack at price/sales 4.3. Overall, the current profile looks closer to a higher-growth but lower-margin setup than a generic broad-market placeholder. Stock Foundry combines TLX price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
TLX
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
TLX Max Drawdown
-62.62%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for TLX and SPY.
Next Step
Earnings pages get much more useful when they are tied back to upcoming dates, expectations, and peer setups.